Cited time in webofscience Cited time in scopus

Full metadata record

DC Field Value Language
dc.contributor.author Brown, Patrick T. -
dc.contributor.author Handorf, Andrew M. -
dc.contributor.author Jeon, Won Bae -
dc.contributor.author Li, Wan-Ju -
dc.date.available 2017-07-05T08:56:39Z -
dc.date.created 2017-04-10 -
dc.date.issued 2013-06 -
dc.identifier.issn 1381-6128 -
dc.identifier.uri http://hdl.handle.net/20.500.11750/2432 -
dc.description.abstract The field of regenerative medicine and tissue engineering is an ever evolving field that holds promise in treating numerous musculoskeletal diseases and injuries. An important impetus in the development of the field was the discovery and implementation of stem cells. The utilization of mesenchymal stem cells, and later embryonic and induced pluripotent stem cells, opens new arenas for tissue engineering and presents the potential of developing stem cell-based therapies for disease treatment. Multipotent and pluripotent stem cells can produce various lineage tissues, and allow for derivation of a tissue that may be comprised of multiple cell types. As the field grows, the combination of biomaterial scaffolds and bioreactors provides methods to create an environment for stem cells that better represent their microenvironment for new tissue formation. As technologies for the fabrication of biomaterial scaffolds advance, the ability of scaffolds to modulate stem cell behavior advances as well. The composition of scaffolds could be of natural or synthetic materials and could be tailored to enhance cell self-renewal and/or direct cell fates. In addition to biomaterial scaffolds, studies of tissue development and cellular microenvironments have determined other factors, such as growth factors and oxygen tension, that are crucial to the regulation of stem cell activity. The overarching goal of stem cell-based tissue engineering research is to precisely control differentiation of stem cells in culture. In this article, we review current developments in tissue engineering, focusing on several stem cell sources, induction factors including growth factors, oxygen tension, biomaterials, and mechanical stimulation, and the internal and external regulatory mechanisms that govern proliferation and differentiation. © 2013 Bentham Science Publishers. -
dc.publisher Bentham Science Publisher -
dc.title Stem Cell-based Tissue Engineering Approaches for Musculoskeletal Regeneration -
dc.type Article -
dc.identifier.doi 10.2174/13816128113199990350 -
dc.identifier.scopusid 2-s2.0-84887394975 -
dc.identifier.bibliographicCitation Current Pharmaceutical Design, v.19, no.19, pp.3429 - 3445 -
dc.subject.keywordAuthor Tissue engineering -
dc.subject.keywordAuthor musculoskeletal tissues -
dc.subject.keywordAuthor biomaterial scaffolds -
dc.subject.keywordAuthor stem cell regulation -
dc.subject.keywordAuthor oxygen -
dc.subject.keywordAuthor growth factors -
dc.subject.keywordAuthor extracellular matrix -
dc.subject.keywordPlus HUMAN BONE-MARROW -
dc.subject.keywordPlus MESENCHYMAL STROMAL CELLS -
dc.subject.keywordPlus BMP-9-INDUCED OSTEOGENIC DIFFERENTIATION -
dc.subject.keywordPlus CANONICAL WNT/BETA-CATENIN -
dc.subject.keywordPlus MATRIX-MEDIATED RETENTION -
dc.subject.keywordPlus FIBROBLAST-GROWTH-FACTOR -
dc.subject.keywordPlus REDUCED OXYGEN-TENSION -
dc.subject.keywordPlus MAINTAINS SELF-RENEWAL -
dc.subject.keywordPlus IN-VITRO GENERATION -
dc.subject.keywordPlus EX-VIVO EXPANSION -
dc.citation.endPage 3445 -
dc.citation.number 19 -
dc.citation.startPage 3429 -
dc.citation.title Current Pharmaceutical Design -
dc.citation.volume 19 -
Files in This Item:

There are no files associated with this item.

Appears in Collections:
Division of Biotechnology 1. Journal Articles

qrcode

  • twitter
  • facebook
  • mendeley

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE